| Financial Year |
March 31 2023 |
| Monetary Funds |
1,151,038,128.93 |
| Held-for-trading Financial Assets |
53,329,326.04 |
| Notes Receivable |
78,911,402.51 |
| Accounts Receivable |
662,125,638.92 |
| Advances to Suppliers |
133,667,627.83 |
| Other Receivables |
3,025,598.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
974,254,506.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,528,293.44 |
| Other Current Assets |
20,058,256.68 |
| Total Current Assets |
3,235,503,779.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,735,301.85 |
| Long-term Equity Investment |
5,667,882.35 |
| Investment Properties |
112,530,886.08 |
| Fixed Assetes |
932,332,433.33 |
| Under-construction Projects |
21,388,295.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
145,968,125.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,074,813.09 |
| Deferred Income Tax Assets |
44,803,352.64 |
| Other Non-Current Assets |
201,587,801.86 |
| Sub-Total of Non-Current Assets |
2,490,889,664.60 |
| Total Assets |
5,726,393,444.47 |
| Short-Term Loans |
390,268,015.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
105,500,000.00 |
| Accounts Payable |
1,092,578,323.90 |
| Accounts Received In Advance |
617,895.07 |
| Employee Compensation Payable |
28,171,697.67 |
| Taxes Payable |
42,431,544.52 |
| Interest Payable |
-- |
| Dividend Payable |
1,660,750.00 |
| Other payables |
43,211,650.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,478,649.49 |
| Other Current Liabilities |
68,520,883.77 |
| Sub-Total of Current Liabilities |
1,807,489,358.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
151,513,250.48 |
| Other Non-Current Liabilities |
594,750.00 |
| Sub-Total of Non-Current Liabilities |
212,957,617.27 |
| Total Liabilities |
2,020,446,975.43 |
| Paid-In Capital(Or Share Stock) |
771,770,000.00 |
| Capital Surplus |
928,236,412.18 |
| Surplus Reserve |
142,068,977.32 |
| LESS:Treasury Stock |
20,597,875.37 |
| Undistributed Profits |
1,375,755,340.71 |
| Minority Stockholder's Interest |
510,605,893.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,195,340,575.72 |
| Owner's Equity（Stockholder's Equity） |
3,705,946,469.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,726,393,444.47 |
